Cargando…
A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease
Insurmountable blood‒brain barrier (BBB) and complex pathological features are the key factors affecting the treatment of Alzheimer's disease (AD). Poor accumulation of drugs in lesion sites and undesired effectiveness of simply reducing Aβ deposition or TAU protein need to be resolved urgently...
Autores principales: | Lei, Ting, Yang, Zhihang, Xia, Xue, Chen, Yuxiu, Yang, Xiaotong, Xie, Rou, Tong, Fan, Wang, Xiaolin, Gao, Huile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727781/ https://www.ncbi.nlm.nih.gov/pubmed/35024324 http://dx.doi.org/10.1016/j.apsb.2021.04.022 |
Ejemplares similares
-
Author correction to “A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease” [Acta Pharmaceutica Sinica B 12, (2021) 4032–4044]
por: Lei, Ting, et al.
Publicado: (2022) -
GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
por: Lin, Congcong, et al.
Publicado: (2020) -
Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection
por: He, Xueqin, et al.
Publicado: (2022) -
Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
por: Zhou, Yutong, et al.
Publicado: (2020) -
Penetration of Water-Soluble Material through Gas-Cleaning Filters
por: Schwarz, Almuth D., et al.
Publicado: (2022)